ErVimmune

France
Mauvezin, Occitanie, France, 69008

Company profile

ErVimmune company profile

ErVimmune creates novel immunotherapies that target non-conventional tumor antigens that are abnormally expressed in cancer cells and shared by tumors and patients, with a particular emphasis on meeting unmet medical requirements in cold malignancies.

Business identity

Contact email
[email protected]
Phone number
+33 6 67 67 44 97
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-10-01, Month

Headquarters

Postal code
69008
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$27.7M
Last funding
Series A / $19.9M / 2026-01-21
Last equity funding
Series A / $19.9M
Investors
4
Lead investors
3
Founders
1
Articles
18

Founders and investors

Founders

Stéphane Depil

Lead investors

BpifranceEIC AcceleratorSeventure Partners

Investors

BpifranceEIC AcceleratorSeventure PartnersSPRIM Global Investments